Full text is available at the source.
Prospects for development of new antimycobacterial drugs
Potential for Developing New Drugs Against Mycobacterial Infections
AI simplified
Abstract
This review examines the development of new antimycobacterial drugs, including fluoroquinolones and macrolides.
- Fluoroquinolones such as ciprofloxacin and levofloxacin show activity against Mycobacterium tuberculosis and Mycobacterium avium complex.
- New macrolides, including clarithromycin and azithromycin, are also evaluated for their effectiveness against these mycobacterial species.
- Rifamycin derivatives like rifabutin and rifapentine are part of the assessment for their in-vitro and in-vivo activities.
- The review includes a brief discussion on the therapeutic efficacy of these drugs in clinical treatment.
AI simplified